Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-218,497
Closed -$153K – 3816
2026
Q1
$153K Buy
218,497
+1,186
+0.5% +$1.11K ﹤0.01% 3140
2025
Q4
$337K Hold
217,311
– – ﹤0.01% 3014
2025
Q3
$343K Hold
217,311
– – ﹤0.01% 3022
2025
Q2
$474K Sell
217,311
-51,230
-19% -$124K ﹤0.01% 2901
2025
Q1
$733K Hold
268,541
– – ﹤0.01% 2767
2024
Q4
$1.12M Sell
268,541
-102,020
-28% -$386K ﹤0.01% 2665
2024
Q3
$1.44M Buy
370,561
+102,020
+38% +$430K ﹤0.01% 2588
2024
Q2
$1.05M Buy
268,541
+20,549
+8% +$88.4K ﹤0.01% 2705
2024
Q1
$1.04M Hold
247,992
– – ﹤0.01% 2692
2023
Q4
$1.17M Buy
247,992
+2,337
+1% +$9.1K ﹤0.01% 2669
2023
Q3
$766K Sell
245,655
-2,964
-1% -$11.9K ﹤0.01% 2684
2023
Q2
$1.14M Hold
248,619
– – ﹤0.01% 2600
2023
Q1
$1.23M Sell
248,619
-106,666
-30% -$525K ﹤0.01% 2533
2022
Q4
$1.94M Sell
355,285
-37,571
-10% -$230K ﹤0.01% 2400
2022
Q3
$2.55M Sell
392,856
-7,375
-2% -$41.1K ﹤0.01% 2274
2022
Q2
$1.89M Buy
400,231
+83,860
+27% +$413K ﹤0.01% 2460
2022
Q1
$2.11M Sell
316,371
-35,017
-10% -$239K ﹤0.01% 2479
2021
Q4
$3.31M Buy
351,388
+281,156
+400% +$3.02M ﹤0.01% 2324
2021
Q3
$858K Buy
+70,232
New +$1.06M ﹤0.01% 3044

Other funds holding MXCT

Nuveen's MXCT Position: Q2 2026 in Review

Nuveen sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 218,497 shares — an estimated $153K sold.

Nuveen first reported a position in MXCT in Q3 2021 and held it in 19 quarters. The position peaked at $3.31M in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Nuveen reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 218,497 MaxCyte shares in Q2 2026, an estimated $153K.
  • Nuveen first reported a position in MaxCyte in Q3 2021 and held it in 19 quarters.
  • Nuveen's MaxCyte position peaked at $3.31M in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.